Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Bone Growth Stimulator Market By Product (Bone Morphogenetic Proteins, Bone Growth Stimulation Devices, Platelet-Rich Plasma), By Application (Delayed Union & Nonunion Bone Fractures, Oral and Maxillofacial Surgeries, Spinal Fusion Surgeries) By End Users (Hospitals & Clinics, Home Care) - Global Opportunity Analysis and Industry Forecast, 2018-2023

 Healthcare and Pharmaceuticals

Report Overview

GLOBAL BONE GROWTH STIMULATOR MARKET was valued at USD 1.15 Billion in the year 2017. Global Bone Growth Stimulator market is further estimated to grow at a CAGR of 4.13% from 2018 to reach USD 1.46 Billion by the year 2023. North America region holds the highest market share in 2017 and Asia-Pacific market is considered as the fastest growing market in the forecasted period due to growing old age population. At a country level, the U.S in North America whereas India and China in Asia-Pacific is projected to grow strongly in the coming years.

Medtronic. Plc (Ireland), Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Bioventus LLC, DePuy Synthes (U.S.) and Harvest Technologies Corporation (U.S.) are some of the key players in the Global Bone Growth Stimulator market. Better global reach at an operational level is the main reason the key players are holding substantial market share. Rising research and development expenses to satisfy the changing demands of end users, new product launches and organic growth strategies were few techniques adopted by various manufacturers in last 5 years.

Drivers:

             Growing old age population

             Adoption of minimal surgical treatment

Restraints:

             High treatment costs

Opportunities:

            Rising pharma sector in emerging market

Challenges:

             Government Regulations and norms.

The segmentation are done on the basis of product type, by application, by end users and by region. On the basis of product types, the global Bone Growth Stimulator market is sub segmented as Bone Morphogenetic Proteins, Bone Growth Stimulation Devices and Platelet-Rich Plasma of which the Bone Growth Stimulation Devices segment is expected to hold the highest market share during the forecast period.

The segmentation done on the basis of application includes Delayed Union & Nonunion Bone Fractures, Oral and Maxillofacial Surgeries, Spinal Fusion Surgeries and Other Applications of which the Spinal Fusion Surgeries segment is expected to hold the highest market share among other applications. On the basis of end users the market is segmented as hospitals & clinics, home Care and others of which hospitals & clinics is expected to grow at the highest CAGR during the forecasted period.

Key Benefits for Stakeholders

Bone Growth Stimulator Manufacturers, Distributors and Retailers

Research and Consulting Organization

Technology Standards Organizations, Forums, Alliances and Associations

End use industries

Regulatory bodies, policy actors and consumers.

By Product

Bone Morphogenetic Proteins

Bone Growth Stimulation Devices

            External Bone Growth Stimulators

            Implanted Bone Growth Stimulators

            Ultrasonic Bone Growth Stimulators

Platelet-Rich Plasma

By Application

Delayed Union & Nonunion Bone Fractures

Oral and Maxillofacial Surgeries

Spinal Fusion Surgeries

Other Applications

End Users

Hospitals & Clinics

Home Care

Others

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Medtronic, plc

Stryker Corporation

Arthrex, Inc.

Regen Lab SA

Altis Biologics (Pty) Ltd

Johnson & Johnson (J&J)

DePuy Synthes

DJO Global, Inc.

Terumo BCT, Inc.

Harvest Technologies (A Terumo BCT Company)

Bioventus LLC

Orthofix International N.V.

(A brief overview of 13 companies is also provided)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1. Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2. Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3. To avoid bias, we filter the collected data collected from authenticated sources.
  4. GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5. Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6. Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet with your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

 

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Bone Growth Stimulator Market, By Product

6.1 Bone Morphogenetic Proteins

6.2 Bone Growth Stimulation Devices

            6.2.1 External Bone Growth Stimulators

            6.2.2 Implanted Bone Growth Stimulators

            6.2.3 Ultrasonic Bone Growth Stimulators

6.3 Platelet-Rich Plasma

7. Bone Growth Stimulator Market, By Application

7.1 Delayed Union & Nonunion Bone Fractures

7.2 Oral and Maxillofacial Surgeries

7.3 Spinal Fusion Surgeries

7.4 Other Applications

8. Bone Growth Stimulator Market, End Users

8.1 Hospitals & Clinics

8.2 Home Care

8.3 Others

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       9.2.3. Mexico

9.3. Europe

       9.3.1. U.K.

       9.3.2. Germany

       9.3.3. France

       9.3.4. RoE

9.4. Asia Pacific

       9.4.1. South Korea

       9.4.2. China

       9.4.3. Japan

       9.4.4. RoAPAC

9.5. RoW

       9.5.1. Latin America

       9.5.2. Middle East and Africa

10. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

10.1 Medtronic, plc

10.2 Stryker Corporation

10.3 Arthrex, Inc.

10.4 Regen Lab SA

10.5 Altis Biologics (Pty) Ltd

10.6 Johnson & Johnson (J&J)

10.7 DePuy Synthes

10.8 DJO Global, Inc.

10.9 Terumo BCT, Inc.

10.10 Harvest Technologies (A Terumo BCT Company)

10.11 Bioventus

10.12 Orthofix International N.V.

 (A brief overview of 13 companies is also provided.)

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

Summary

No Content Available.